Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 20, 2015The Journal of Clinical PsychiatryOpen Access

The Primary Outcome Measure and Its Importance in Clinical Trials

View Full Paper
Ask AI
Bookmark
Share

Authors

CAChittaranjan AndradeManipal Academy of Higher Education

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chittaranjan Andrade (2015) studied this question.

synapsesocial.com/papers/6ab320aff478279d58c8e6c0https://doi.org/10.4088/jcp.15f10377
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression1999 · 1,062 citations
  2. 2Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use2009 · 367 citations
  3. 3Primary and secondary outcome measures2010 · 11 citations
  4. 4Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials2008 · 438 citations